Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesMRIfMRI: Cognitive behavioral therapy positively affects the brainThe findings confirm the efficacy of the treatment, researchers have reported.Molecular ImagingExperts issue appropriate use criteria for molecular breast imagingCTSafety concerns lead to suspension of CT service at Belgian hospitalMRIMRI shows how brain maintains 'representation' of phantom limbsMRIGadolinium in ... beer?